Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghaith Aljayyoussi

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|April 1, 2024
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in miceMatthias J Düchs, Ramona F Kratzer, Pablo Vieyra-Garcia, et al.
The Lancet. Infectious Diseases|January 18, 2020
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling studyHannah C Slater, Brian D Foy, Kevin Kobylinski, et al.
International Journal of Antimicrobial Agents|January 30, 2022
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2Laura N Jeffreys, Shaun H Pennington, Jack Duggan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2018
Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial)Menno R Smit, Eric O Ochomo, Ghaith Aljayyoussi, et al.
Scientific Reports|January 9, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Aljayyoussi, Hayley E Tyrer, et al.
Clinical Pharmacology and Therapeutics|August 21, 2018
Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL)Menno R Smit, Eric O Ochomo, David Waterhouse, et al.
The Lancet. Infectious Diseases|April 1, 2018
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trialMenno R Smit, Eric O Ochomo, Ghaith Aljayyoussi, et al.
Frontiers in Microbiology|February 16, 2024
Combinations of the azaquinazoline anti-<i>Wolbachia</i> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisShrilakshmi Hegde, Amy E Marriott, Nicolas Pionnier, et al.
Scientific Reports|March 18, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Scientific Reports|January 20, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|April 1, 2024
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in miceMatthias J Düchs, Ramona F Kratzer, Pablo Vieyra-Garcia, et al.
The Lancet. Infectious Diseases|January 18, 2020
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling studyHannah C Slater, Brian D Foy, Kevin Kobylinski, et al.
International Journal of Antimicrobial Agents|January 30, 2022
Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2Laura N Jeffreys, Shaun H Pennington, Jack Duggan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2018
Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial)Menno R Smit, Eric O Ochomo, Ghaith Aljayyoussi, et al.
Scientific Reports|January 9, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Aljayyoussi, Hayley E Tyrer, et al.
Clinical Pharmacology and Therapeutics|August 21, 2018
Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL)Menno R Smit, Eric O Ochomo, David Waterhouse, et al.
The Lancet. Infectious Diseases|April 1, 2018
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trialMenno R Smit, Eric O Ochomo, Ghaith Aljayyoussi, et al.
Frontiers in Microbiology|February 16, 2024
Combinations of the azaquinazoline anti-<i>Wolbachia</i> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisShrilakshmi Hegde, Amy E Marriott, Nicolas Pionnier, et al.
Scientific Reports|March 18, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Scientific Reports|January 20, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Pageof 5